Divergence, Inc. is a biotechnology company focused on reducing the impact of parasitic nematode worms, devastating unseen pests that cause billions of dollars in crop losses annually and substantial morbidity to people, livestock, and pets.

Sustainable food production and improved human health depends upon innovation in biotechnology. We apply innovation to the control of parasitic nematode worms in plants and in human and veterinary medicine. For example, Divergence is developing the first novel modes of action in decades for the plant nematode control market. The privately held company operates from laboratories at the Bio-Research & Development Growth (BRDG) Park in St. Louis, Missouri and collaborates with leading companies in plant biotechnology and animal health.